I. INTRODUCTION
A WELL-ACCEPTED paradigm explaining cancer development is that of clonal evolution of tumor cell populations [1] , [2] . The cells that have a proliferative advantage become the majority of the cells making up the neoplastic tissue. The stepwise accumulation of mutations in cancer tissues causes the appearance of variant subpopulations, which makes the cancer tissue heterogeneous. Other theories attempting to explain the cancer development include the cancer stem cell theory [3] - [6] , which suggests that the behavior of cancers is mostly dictated by small subpopulations of cancer stem cells. All these theories point to the heterogeneous nature of cancer tissues, which makes the treatment more difficult. A certain therapy that may be effective in one case of a particular kind of cancer may not work for other cases. Determining the proportion wise breakup of a given cancerous tissue is hence an important problem in the context of cancer therapy. Once the dominant subpopulations have been identified, the appropriate decisions regarding therapy can be taken such as which subpopulation to target and how much of therapy should be administered to the patient. Mathematical models of the regulatory networks of cancerous tissues must be made taking this heterogeneous nature of cancer tissues into consideration. These models can provide much needed insight into how to go about effectively treating the cancer.
An attempt was made in [7] to model cancer tissue heterogeneity. In that paper, the authors used a collection of Boolean networks to model the various subpopulations in a given tissue. A multilevel hierarchical model was used to model the extent to which each Boolean network affects the behavior of each of the observed gene expressions. The authors demonstrated the use of this model by applying it to gene expression measurements from healthy fibroblasts when they were exposed to various stimuli. Markov chain Monte Carlo (MCMC) methods were used to estimate the posterior probability distributions of the unknown parameters, which would indicate the proportion wise breakup of the tissue under study. In this paper, we make certain approximations to the model that would allow us to employ faster (variational) methods to carry out the same estimation.
II. MOTIVATION
Modeling cellular behavior is the first step toward a unified understanding of the multivariate interactions among various genes. Gene regulatory networks provide a means to model and predict cellular behavior. Using such models could facilitate the development of better therapies that could shift the state of the cancer tissues toward more desirable ones. Various methods to model gene regulatory networks have been developed, such as differential equations [8] , deterministic and probabilistic Boolean networks [9] , [10] , and Bayesian and dynamic Bayesian networks [11] , [12] . Some methods are based on the assumption that the transition probabilities are already provided. Such assumptions are, however, unrealistic from a practical standpoint since the large amount of data needed to reliably determine these transition probabilities is difficult to collect. Some methods such as the REVEAL algorithm [13] learn deterministic Boolean networks from discretized timedomain data. Many of these methods rely on the discretization of continuous valued data, which may result in the loss of information. The ARACNE method [14] is an approach to determine regulatory interactions from continuous valued measurements. In [15] , the authors described a Bayesian method for inferring pathway structures from high throughput quantitative genetic interaction measurements. In [16] , the authors reported an integrated whole-cell computational model of the life cycle of the human pathogen Mycoplasma genitalium that includes all of its molecular components and their interactions. However, such a model is dependent upon in-depth knowledge about the various cellular dynamics of the system being modeled and can be applied to the simplest of systems (Mycoplasma genitalium has only 525 genes [16] ). It is difficult to apply the same approach to model a complex system such as a cancerous tissue.
Prior knowledge about regulatory interactions can be used to reduce the dependence on large volumes of data. Such prior knowledge can be garnered from the biological literature, which contains a lot of information regarding such regulatory interactions between the various biological molecules. Such prior knowledge can be used to develop models of regulatory networks, which describe cellular behavior more accurately.
A method to take advantage of prior knowledge is presented in [17] , where the authors used Karnaugh maps to systematically generate Boolean networks from marginal pathway knowledge. In [18] , the authors used this technique to generate a Boolean network of the mitogen activated protein kinase (MAPK) signal transduction network, which is a broadly accepted signaling network. This network is shown in Fig. 1 . The figure also includes the targets of a few highly specific kinase inhibitory drugs.
This Boolean network is an abstraction of the interactions between the various genes and/or proteins involved in the signal transduction network. A lot of the biological entities involved in the transduction network have a binary state associated with them. For example, a protein may have two states, a phosphorylated state and an unphosphorylated state, which may be represented as one or zero. Hence, a Boolean network with logic gates like AND, OR, and NOT may be used to accurately represent their interactions. For an in-depth treatment of the correspondence between the Boolean network elements and their corresponding biological entities, the reader is referred to [17] and [18] .
In [18] , the authors represented a "stuck-at" fault model of cancer causing mutations. A stuck-at-one fault corresponds to a variable permanently being in an activated state irrespective of the states of the variables upstream of it. Similarly a stuckat-zero fault would mean a variable has a permanently downregulated state irrespective of the states of the other upstream variables. This allows the well-developed techniques of digital circuit testing to be applied in the analysis of signal transduction networks, which can then be used to design combination therapies for a given type of cancer tissue. In [7] , the authors used an ensemble of Boolean networks to represent a given cancer tissue. In this model, the subpopulations or networks in the collection of chosen networks exert their effect on the observable variables (the gene expression ratios) in a weighted average fashion. The objective was to find these weights associated with each subpopulation or network in the ensemble. This problem was solved using Markov chain Monte Carlo (MCMC) methods. In this paper, we will address this problem of finding out these weights in a variational Bayes framework resulting in a significant speed-up of the computational time.
Prior knowledge about the qualitative location of faults in the network can be used to determine the initial model and which networks to choose in the ensemble. For instance, in 30% of human breast cancers, we see an over expression of the ERBB2 gene [2] . This can be interpreted as a stuck-at-one fault at the variable corresponding to ERBB2 in the Boolean network in Fig. 1 . Another example is that of the pancreatic cancer, where 90% of the cases show a mutated Ras gene [2] translating to a stuck-at-one fault in the corresponding location in the Boolean network. Using prior knowledge such as the possible locations of faults as described earlier, and other factors, such as the origin of the cancer tissue, it is possible to decide which networks to include in the ensemble.
III. METHODS
Once the networks to be included in the ensemble have been chosen based on prior knowledge, the problem is to estimate the weights associated with each of the networks from collected data. The observable variables can be anything in principle. We will develop our methods based on normalized gene expression ratios. These are real-valued readings for each gene. Livak and Schmittgen [19] discussed the method to measure normalized gene-expression ratios using quantitative polymerase chain reaction (QPCR). When exposed to a certain stimulus (like a particular combination of kinase inhibitory drugs), some of the output variables, as shown at the bottom of Fig. 1 using arrows, will be upregulated or one for some of the Boolean networks in the ensemble, and some of the output variables will be downregulated or zero for some of the other networks in the ensemble. For example, let us consider an example where we have three networks in the ensemble. Let the first subpopulation be modeled by a Boolean network with a stuck-at-one fault at ERK1/2, let the second subpopulation have two stuck-at-one faults at ERBB2/3 and Raf, and let the final subpopulation have a stuck-at-zero fault at PTEN. The different fault locations corresponding to the different subpopulations are shown as shaded squares in the single Boolean network in Fig. 1 . Suppose we expose the cell culture to the drug U0126. This is a kinase inhibitor that targets MEK1 as shown in Fig. 1 . (All the drugs used in this example are kinase inhibitors whose molecular targets are shown in Fig. 1 .) Let us also assume that the serum, as typically used in tissue cultures, has EGF, HBEGF, IGF, and NRG1 in it. Hence, in other words, the corresponding variables represented at the top of Fig. 1 are all one or upregulated. If we observe the behavior of the transcription factor SP1 (shown at the bottom of the Boolean network in Fig. 1 with an arrow), the first network has SP1 upregulated, while in the second and third networks, SP1 will be downregulated. If we are observing the expression for a gene that has the SP1 response element (such as cMYC), then that gene will be influenced by just the first network to an extent determined by the weight assigned to that network.
We can represent the activities of the different Boolean networks with relation to the ith gene (the three Boolean networks with relation to cMYC in the aforementioned example) using a vector d i = 1 0 0 T , where the subscript i stands for the ith gene. We define this vector as the "expression profile" [7] . This expression profile will depend on the stimulus given to the tissue (the combination of the kinase inhibitor drugs for example) and the networks included in the ensemble. These expression profiles will be provided along with the data. Let the weights associated with the three networks with relation to the ith gene be represented by a vector
Then, if we are considering a model that combines the networks in a weighted average fashion, then the gene expression for the ith gene in the overall model could be quantified by the dot product d T i α i . Assuming the weights associated with each network to be the same with relation to all the genes being observed is a strong assumption. That is, assuming all the α i weight vectors to be the same would imply that the Boolean networks affect all the genes with exactly the same ratio. The model should allow for the weights associated with each network to be different for the various gene expression measured and yet allow them to be somewhat related to each other. This hints toward the use of Hierarchical modeling of the weight vectors α i 's.
A. Short Summary of Previous Work
Here, we present a short summary of the previous work done in [7] . The reader may skip directly to the next section for a description of the conjugate exponential model approach. Fig. 2 . Bayesian network representing the probability model used in [7] .
In [7] , the normalized gene expression ratios were modeled as a ratio of two normal random variables. This method was an extension of the model described in [20] . Let us say that several measurements of the ith gene were made. Let d i,j be the "expression profile" for the jth measurement of the ith gene. d i,j will depend on the drugs to which the tissue was exposed and on the faulty Boolean networks included in the ensemble. Let r i,j be the corresponding measured gene expression ratio for the ith gene. Then, [7] 
where
The parameter c is the coefficient of variation used to account for the uncertainty in the data. For a detailed derivation of (1), the reader is referred to [7] .
Such a distribution has a mode close to around m i,j . A multilevel hierarchical model was used, where each of the weight vectors α i associated with the ith gene is different from the weight vectors associated with the other genes, but they all are derived from an underlying distribution, which is an average of all the weight vectors. A schematic diagram of the Bayesian network of the probability model used in [7] is shown in Fig. 2 . The parameter K governs the topmost level of the model. Assuming that there are V different observable variables or genes being measured, and each gene i has n i observations associated with it (which may come from different experiments), the variables r 1,1 through r V ,n V in Fig. 2 indicate the observed gene-expression data. The expression profile associated with each observation indicates how each network is affecting the output variable. These expression profiles are not shown in the diagram. The variables α 1 through α V indicate the weight vectors associated with each of the genes being observed. In [7] , the authors constrained all the components of each α i vector to be nonnegative and their sum to one. The logical choice was to make all the α i 's to be sampled from an underlying Dirichlet distribution with a parameter vector K. The larger the values of the elements of K, the closer all the α i 's are to each other. Learning this unknown parameter K from the collected data would indicate the proportion wise breakup of the tissue.
The model parameters were learned in [7] using the Metropolis-Hastings algorithm, which is a MCMC-based method. The problem with such a method is that it is very computationally intensive. There are problems of convergence, especially since it may be difficult to judge if the Markov chain has reached stationarity. In addition, the mixing may be poor that will require us to use thinning to get a decent effective sample size, which further increases computation time.
To get around the use of MCMC methods, in this paper, we have resorted to the use of variational methods to estimate the posterior distributions of the unknown parameters. These methods involve assuming the distribution to have a certain factorized form and iteratively refining these factors. The variational method can be conveniently applied to the conjugate exponential family of models [21] . Hence, we approximate the model for heterogeneous cancer tissue presented in [7] in the form of such a conjugate exponential model and derive the corresponding iterative update equations.
B. Conjugate Exponential Model for Cancer Tissue Heterogeneity
The Bayesian network of the model is shown in Fig. 3 . Let the number of genes whose expression levels were measured be V . Then, there would be V different weight vectors α i 's, each vector being associated with a particular gene. The number of elements in each weight vector α i is the same and equal to the number of Boolean networks in the ensemble. Let the number of observations made for the ith gene be n i . Let us represent the jth observation of the ith gene by r i,j . Hence, each r i,j runs from r i,1 through r i,n i as shown in Fig. 3 . Each observation r i,j is made to be Normally distributed with a mean of d T i,j α i and a precision of ρ (variance of ρ −1 ), where d i,j is the "expression profile" associated with the observation r i,j . The expression profile depends on the behavior of the networks included in the ensemble and the stimulus provided to the tissue in the form of kinase inhibitory drug combinations and is provided along with the observed data. All the α i 's come from an underlying Gaussian distribution with a mean of K and a precision matrix of Λ (a covariance matrix of Λ −1 ). The variables Λ, K, and ρ are the unknown parameters that need to be determined. The parameter K is of interest since this indicates the weights associated with the different Boolean networks in the ensemble. The individual weight vectors α i 's indicate the effect exerted by each network in the ensemble on the expression values measured for each gene and will vary from gene to gene and will depend on the data collected, and hence, are not interchangeable among the various genes. In other words, the weight vectors are identifiable. The parameter K will give an averaged bird's eye view of the effect of each network in the ensemble.
Since we are concerned with the ratio with which the different networks affect the observed gene expressions, we can reduce redundancy by constraining the elements of each weight vector α i to sum to 1, as was done in [7] . That is
where N is the number of networks in the ensemble. Therefore, we have
For convenience, we are not constraining the elements of the weight vectors to be nonnegative. As we will see from simulations and from applications to real data, the posterior distributions of these elements will have very little probabilities in the regions where any element is negative. The probability distribution of any gene-expression reading is defined to be normally distributed with a mean of d T i,j α i and a precision of ρ (inverse of variance). We are considering all the measured gene-expression ratios to have the same precision, although it is possible to have a hierarchical structure for the precision too. From (2), we have d Define
T , and
The probability distribution of β i is defined to be normally distributed with a mean of K and a precision matrix of Λ, where
Hence, the unknown parameters are ρ, K, and Λ, which in the Bayesian framework are simply unobserved variables (along with all the β i 's). K could be interpreted as the weights associated with the first N − 1 networks. 1 − N −1 q =1 K q could be interpreted as the weight associated with the N th network.
The Bayesian approach needs us to define certain priors over the unknown parameters. Thus, we define the prior over ρ to be a gamma distribution with a shape and inverse scale parameter to be a o and b o , respectively. The prior over K and Λ was taken as the normal-Wishart distribution. Thus, we have
and
where K o , q o , n o , and Λ o are constants.
The joint posterior distribution of the unknown variables is
where β is the set of all the β i 's and r is the set of all the observed data. Our model belongs to the conjugate exponential family. Conjugate exponential models are those where the conditional distributions involved in the model belong to the exponential family and are conjugate with respect to the parent variables [21] . The hierarchical model described before falls in this category. In the following section, we will approximate the joint posterior distribution of the unknown variables using the variational approach. This would in turn simplify the derivation of the marginal distributions of the variables of interest (such as K, which would indicate the proportion wise breakup of the tissue).
Variational methods in Bayesian inference proceed by assuming a certain factorized form of the joint posterior distribution of the unobserved variables [22] . This factorization is done by first partitioning the unobserved variables into disjoint groups. For example, let us say that we have a set of unobserved variables Z and we want to find an approximation of P (Z/D), which is the posterior distribution of the unobserved elements conditional on the observed data D. We approximate this by Q (Z), where
Z 1 through Z M are disjointed partitions of the set Z [22] . Then, the method proceeds to minimize the KullbackLeibler (KL) divergence KL (Q(Z)||P (Z/D)). It should be noted that
A derivation of (10) can be found in [22] . As the KL divergence is minimized, the lower bound L Q (D) increases monotonically. This can be used to check if the minimization algorithm has achieved convergence. Also the maximum achieved lower bound can be used for the model selection.
The KL divergence is minimized using the following update equation: (12) for each j, from 1 through M . The constant term can be adjusted to make sure that Q j (Z j ) is a proper probability distribution, that is it integrates to 1. For a detailed derivation of (12), the reader is referred to [22] . Equation (12) shows that the optimum Q j (Z j ) depends on the other factors Q i (Z i ) for i = j. Hence, the equations are solved iteratively by first initializing the parameters that describe each distribution Q j (Z j ) to appropriate values and cycling through the equations and replacing the old values with the corresponding updates. The variational method can be applied in a straightforward manner to the class of conjugate exponential models. Therefore, we can use the variational framework to estimate the proportion wise breakup of the tissue under study.
C. Derivation of the Variational Update Equations
The approximation Q (ρ, β, K, Λ) of the posterior P (ρ, β, K, Λ/r) is assumed to factorize in the following form:
We then use (12) to derive the update equations for each of the factors. First, we apply (12) to Q ρ (ρ). As per (12), we have
The terms that are not dependent on ρ can be absorbed into the constants. Thus, we get
Upon simplifying, we get
and constants are all those terms that do not depend on ρ. Looking at the form of (19), we can deduce Q ρ (ρ) to be gamma distributed with a ρ as the shape parameter and b ρ to be the inverse scale parameter. That is 
This factorization is not implicitly assumed, but comes as a result of applying (12) to derive the update equations for Q β (β). Upon inspection, Q β i (β i ) comes out to be normally distributed as follows:
where Λ β i is a (N − 1) × (N − 1) positive semidefinite precision matrix and μ β i is the mean vector of length N − 1, which are defined as
All the expectations in (22) and (23) are done with respect to Q ρ (ρ)Q K ,Λ (K, Λ). Following similar steps, Q K ,Λ (K, Λ) comes out to be factorizable as Q K ,Λ (K/Λ)Q K ,Λ (Λ), which are defined as follows:
where K oK and Λ
−1
oΛ are defined as
(27) K oK and Λ oΛ are of length N − 1 and of dimension (N − 1) × (N − 1), respectively. Now that the optimal form of each factor in the approximation is known, the expectations can be easily computed. Thus, we get
The constants a ρ , b ρ , Λ β i , μ β i , K oK , and Λ oΛ are all initialized to appropriate values, and then, iteratively updated by cycling through the update equations (18), (19) , (22), (23), (26), and (27) using the values of the expectations shown in (28) through (33). Equation (11) is used to calculate the lower bound at each iteration. In the interest of space, the exact equation of the lower bound is not shown here. However, in our simulations and applications to real-world data, we will show how convergence is judged using the lower bound.
D. Simulation Experiments
To demonstrate the algorithm, we ran simulations on synthetic data. First, the synthetic data were generated from the following example. Three different Boolean networks with stuck-at faults were taken in the ensemble. The first network was chosen to have a stuck-at one fault at Ras. The second network was chosen to have a stuck-a-zero fault at PTEN. The third network was chosen to have a stuck-at-one fault at RAF. Hence, N = 3. The three locations are shown as shaded squares in a single Boolean network in Fig. 1 . The activity of the four transcription factors shown at the bottom of Fig. 1 would be different in the three networks for any given drug combination. A total of 63 different drug combinations were chosen as the stimulus. The location of the targets of these kinase inhibitory drugs is shown in Fig. 1 . Since there are six different drugs, there would be 63 different possible combinations excluding the case of no drug exposure. It was assumed that five genes per transcription factor were measured, hence, a total of 20 different observable variables were assumed in the simulation. Hence, V = 20. Each experiment was repeated ten times in the simulation. This would result in each observable being observed ten times. Hence, n i = 10 for all i's ranging from 1 to 20. Since the number of networks is three, hence, the length of the vector K is two. K was set to be 0.1 0.3 . Hence, the first network has a weight of 0.1 associated with it, the second network has a weight of 0.3 associated with it, and the third network has a weight of 0.6 associated with it. ρ was set to be 100 and Λ was set to be Λ = 0.01 0.005 0.005 0.008
For the purposes of demonstration, the parameters for the prior distributions of the parameters were chosen as follows. a o and b o for the prior over ρ were both chosen to be 0.5. This would make the prior over ρ to have a mean of 1. K o was chosen to be 1/3 1/3 T and q o was chosen to be 0.001.
Hence, the prior belief assigns equal weights to all the three networks. The small value of q o means that the prior is spread out and noninformative. As for the prior over Λ, n o was chosen to be 1.1 and Λ o was chosen as For comparison purposes, we also did the posterior inference using Gibbs sampling and found point estimates of the unknown parameters using an expectation maximization algorithm. The full conditionals of the unobserved variables in the Gibbs sampling algorithm are listed below. (Some of the notations used here are similar to those used in the derivation of the variational update equations. The reader is advised to keep in mind that the full conditionals are derived independent of the derivations in the previous subsection.)
The full conditional of Λ is
The full conditional of K is
The full conditional of ρ is
The full conditionals of each of the β i 's are
The expectation maximization algorithm can also be used to find a maximum likelihood estimate of the unknown parameters ρ, K, and Λ. The hidden variables that are not observed are simply all the β i 's for i ranging from 1 through V . The derivation is skipped in the interest of space. The expectation maximization update equations are as follows. Define ρ (n ) , K (n ) , and Λ (n ) to be the estimates of the parameters in the nth iteration. Define
Then, the update equations are
where ρ (n +1) , K (n +1) , and Λ (n +1) are the updated values of the parameters.
In the Bayesian framework, we get the posterior distribution of the unknown parameters from which we can get point estimates as well, whereas the maximum likelihood estimate obtained using expectation maximization algorithms provide only point estimates. The posterior distributions can be used to judge the reliability of the data in estimating the unknown parameters, since if the posterior distribution is too spread out beyond what would be considered acceptable in that particular application, then we may consider the estimates to be unreliable and would be inclined to collect more data. This makes variational Bayesian approach advantageous over the maximum likelihood approach. The Bayesian method also allows us to incorporate any prior knowledge about the weights into the prior distributions.
In general, MCMC methods take orders of magnitude more time than iterative Bayesian methods such as variational Bayes, belief propagation, expectation propagation, etc. This was also true in our case. In the simulation example, the variational algorithm converged in less than 30 s, where as the MCMC algorithm had to be run for more than 30 min to get effective sample sizes on a computer with a 64 bit 2.53 GHz CPU. Since variational Bayesian method provides posterior distribution of the unknown parameters while EM simply provides point estimates, both these methods can not be compared since their purposes are different. However, both these methods took about the same amount of time to converge. Fig. 4 shows the posterior marginal distributions of the elements of K derived using both the Gibbs sampling method as well as the variational Bayesian method. The third graph in 
As we can see, the distributions computed using both the methods are almost identical. It is our observation that as the number of data points increases, the distributions given by the variational method and the MCMC method tend to agree with each other more and more. Hence, more the number of data points, more reliable the variational methods become. Same is true for the posterior distribution of ρ, which is shown in Fig. 5. Fig. 6 shows how the lower bound stops improving after 80 iterations of the variational algorithm thereby indicating convergence. The lower bound can be used to judge convergence by various ways. In our example, when the change in the lower bound with increasing iteration number fell below a certain threshold, the variational Bayes algorithm was terminated. The iterative variational algorithm is guaranteed to converge to a local maxima [21] . The mean of the posterior distribution of K comes out to be (0.1044, 0.3015) T and (0.1042, 0.3011) T from the variational method and the Gibbs sampling method, respectively. The maximum likelihood estimate of K using the expectation maximization algorithm comes out to be (0.1042, 0.3015)
T . Fig. 7 shows that the log likelihood function shows no significant improvement after 100 iterations of the expectation maximization algorithm, thereby indicating convergence. All three estimates are close to the actual value of (0.1, 0.3)
T thereby showing the correctness of the algorithms.
From Fig. 4 , we can see that the marginal posterior distributions of the elements of K lie mostly within the interval (0, 1). The marginal posterior distribution of 1 − N q =1 K q (the third graph in Fig. 4 ) also lies within the interval (0, 1). Hence, the bulk of the probability distributions of all the elements of K lie in the valid region (nonnegative and lesser than 1).
Random restarts of the variational algorithm were attempted with various initializations of K oK . The log lower bound always converged to the value of 7253.79076. The variational algorithm was also run with various values of the prior parameter K o . Since the prior chosen was weak owing to the small value of q o , the posterior distribution was not strongly affected by the prior. A small effect on the log lower bound was observed. These values are shown for five such random values of K o in Fig. 8 .
To judge the accuracy of the three methods, we generated random K vectors from the first two elements of a 3-D Dirichlet distribution with parameter vector (1, 1, 1) T and computed the Euclidian distance of the point estimates generated by the three methods from the actual value of K for ten different such random values of K. The average Euclidean distance errors came out to be 0.00449, 0.00454, and 0.00446 for the variational method, the MCMC method and the expectation maximization method, respectively, indicating that the methods give similar performance in accuracy. 
E. Verification Using Experimental Data
In order to test the model, we need to collect data from a tissue where the dominant population or the dominant network is already known. In a cancerous cell line, one cannot be sure which network is dominant. But in a normal cell line, such as adult fibroblasts, it is fair to assume that a network modeling a faultless MAPK signal transduction network would be the most dominant one, no matter what other networks are included in the ensemble. Hence, we performed a simple experiment on adult fibroblasts to demonstrate the approach. For a detailed description of the wet lab procedures, the authors are referred to [7] . The experiments were performed on three groups of cell cultures. The first group was not exposed to any kinase inhibitory drugs and served as the control. The second and third groups were exposed to the drugs LY294002 and a combination of LY294002 and U0126, respectively. Their target locations are shown in Fig. 1 . Glyceraldehyde-3-phosphate dehydrogenase was used as the reference gene. Genes having the SP1 or the SRF-ELK response elements in their promoters were quantified through real-time PCR and the delta-delta method [19] . A total of ten different genes (including alternative transcripts) were quantified [7] . Hence, V = 10. Their measured expression values are shown in Table I . Generally regulatory network studies work with hundreds if not thousands of genes, such as in [11] , [14] , and [20] , which use microarray data. Here, we are working with ten genes. Addition of more data would only improve the reliability of the posterior estimates.
For the sake of demonstration, we assumed three networks to be in the ensemble. Hence, N = 3. Network 1 has no mutations, i.e., no stuck-at faults. This network models the normally behaving fibroblasts. Network 2 is assumed to have a stuck-at-one fault at ERK1/2 and network 3 is assumed to have stuck-at-one faults at SRF-ELK1 and SRF-ELK4. The "expression profiles" for all the genes for the experimental conditions of the second and third groups are known (can be easily derived from Fig. 1 ) and depend on the behavior of the three networks included in the ensemble. These are shown in Table I .
The marginal posterior distributions of the elements of K are computed using the variational approach and are shown in Fig. 9 . The lower bound stops improving after 300 iterations as can be seen in Fig. 11 , thereby indicating convergence. Only the results of the variational computations are shown since the MCMC approach could not produce decent effective sample sizes. As we can see, most of the probability mass lies in the valid region. Specifically, most of the posterior marginal probabilities associated with the elements of K are within 0 and 1. Hence, we get meaningful interpretations of the inferred value of K. The mean of the posterior distribution of K comes out to be 0.6716, 0.2740 T . As expected, the first faultless network representing normal fibroblasts has the maximum influence on the behavior of the observables, close to 67%. The other two networks have influences of 27% and 6%, respectively. The authors in [7] reported values of 0.6453 0.2255 0.1292 T , which are very close to those calculated in this paper. The posterior distributions are tightly distributed relative to the domain (0, 1), and hence, the point estimates can be considered reliable. Collecting more data would only result in sharper posterior distributions, and hence, more reliable estimates of the unknown parameters. Such a judgment about the reliability of the point estimates is straightforward in a Bayesian approach. The marginal posterior distribution of ρ computed using variational algorithm is plotted in Fig. 10 .
The expectation maximization algorithm also gives very close values of 0.6764 0.2745 0.0490
T . The log likelihood stops improving after 250 iterations of the expectation maximization algorithm as can be seen in Fig. 12 , thereby indicating convergence. This simple experiment shows how this model can be used to determine the proportional breakup of the subpopulations in a heterogeneous tissue. In the case of larger models, to ensure that the variational algorithm does not get stuck at a local maxima, random starts with different initializations could be attempted and the solution with the maximum steady-state lower bound could be selected. In our case, the variational algorithms converged to posterior distributions, which were to be expected (the results agreed with results from previous work in [7] ). Hence, random initializations were not attempted.
The effect exerted by the Boolean network corresponding to the healthy tissue comes out to be around 67%. This is almost two and a half times the weight assigned to the second most dominant network. Acquiring more data might result in more weight being assigned to the faultless network.
IV. CONCLUSION
In this paper, the problem of heterogeneity in cancer tissue cell populations was addressed and a model was developed that uses a collection of different Boolean networks to model the various subpopulations in the tissue. It was demonstrated using both synthetic and real-world data collected from fibroblasts, how this model can be used to find out the relative abundance of the various subpopulations in a given tissue under study using QPCR gene expression data. This paper is an extension of the previous work in [7] . The novelty of this study is in the improvement in the computation time. A hierarchical conjugate exponential model was used in this paper, which allowed the use of variational methods for Bayesian estimation of the relative abundances of the various subpopulations. The efficacy of the variational methods was verified by comparing the results obtained to those obtained using MCMC (Gibbs sampling) and maximum likelihood (expectation maximization) methods. Determining the relative abundance of the various subpopulations in an individual patient could be used to come up with customized combination therapies that are tailored to the patient so as to improve the efficacy and reduce side effects (for example, we may want to target the dominant subpopulation(s) using the minimal amount of drugs so as to reduce side effects).
Variational methods are becoming increasingly important as Bayesian methods are gaining interest since these methods allow for speedy computation of posterior distributions of variables of interest. Moreover, the lower bound, which is easily computed in variational methods, provides for an effective proxy for the likelihood of the data that can be used for model selection. Prior probabilities could also be assigned to these models, which when combined with the maximum achieved lower bound would provide a given search algorithm a metric to compare different ensembles of Boolean networks. The design of this search algorithm is an open problem that needs to be addressed in a separate work. Such a search algorithm will likely be a heuristic, which searches through the space of ensembles comparing them to converge on one that best fits the data. Hence, this approach can also be extended to solving the problem of determining how many Boolean networks to include in the ensemble as well as determining which Boolean networks to include in the ensemble. Besides variational methods, other methods, such as expectation propagation may also be used to solve the problem of determining the dominant subpopulations in a heterogeneous cancer tissue in a Bayesian framework with reduced computational requirements.
The model in this paper was developed keeping QPCR geneexpression data in mind. However, similar methods can be developed that use data from more state of the art technologies such as next generation sequencing and flow cytometry. Ensembles of Boolean networks are an example with which this paper has explored the idea of hierarchically modeling weights. This idea may be extended to developing models that consist of ensembles of differential equations, dynamic Bayesian networks or other similar models, which are better suited to taking into account cell dynamics.
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